Parkinson Diseases in the 2020s and Beyond: Replacing Clinico-Pathologic Convergence With Systems Biology Divergence

Parkinson disease has been considered for practical purposes a heterogeneous clinico-pathological entity. The operational definition requires clinical ascertainment of a levodopa-responsive parkinsonism with no “atypical” features, and pathological criteria based on the finding, usually at postmorte...

Descripción completa

Detalles Bibliográficos
Autores principales: Espay, Alberto J., Lang, Anthony E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311362/
https://www.ncbi.nlm.nih.gov/pubmed/30584155
http://dx.doi.org/10.3233/JPD-181465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311362/
https://www.ncbi.nlm.nih.gov/pubmed/30584155
http://dx.doi.org/10.3233/JPD-181465

Ejemplares similares